Journal
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
Volume 26, Issue 9, Pages 2267-2276Publisher
AMER SOC NEPHROLOGY
DOI: 10.1681/ASN.2014030309
Keywords
-
Categories
Funding
- Austrian National Bank [15883, 14263, 14853]
- Austrian Science Fund(FWF) [P22521-B18, P22976-B18]
- Medical University of Graz within the framework of Program DK-MOLIN [FWF-W1241]
- Austrian Science Fund (FWF) [P 22521, P 21004, P 22976] Funding Source: researchfish
- Austrian Science Fund (FWF) [P22976, W1241] Funding Source: Austrian Science Fund (FWF)
Ask authors/readers for more resources
Lipid abnormalities may have an effect on clinical outcomes of patients on dialysis. Recent studies have indicated that HDL dysfunction is a hallmark of ESRD. In this study, we compared HDL composition and metrics of HDL functionality in patients undergoing hemodialysis (HD) or peritoneal dialysis (PD) with those in healthy controls. We detected a marked suppression of several metrics of HDL functionality in patients on HD or PD. Compositional analysis revealed that HDL from both dialysis groups shifted toward a more proinflammatory phenotype with profound alterations in the lipid moiety and protein composition. With regard to function, cholesterol efflux and anti-inflammatory and antiapoptotic functions seemed to be more severely suppressed in patients on HD, whereas HDL-associated paraoxonase activity was lowest in patients on PD. Quantification of enzyme activities involved in HDL metabolism suggested that HDL particle maturation and remodeling are altered in patients on HD or PD. In summary, our study provides mechanistic insights into the formation of dysfunctional HDL in patients with ESRD who are on HD or PD.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available